81qd

Next week, we’re joining industry experts at the 4th Annual Thought Leader Liaison Engagement Summit to dive deeper into the latest TLL strategies. 81qd is proud to be a silver sponsor for this event, the only thought leader liaison-focused conference in the Pharma Industry. If you’re heading to Philly and attending, don’t be a stranger – connect with our team! Learn more about this event and 81qd's involvement at https://lnkd.in/eeaKAUhM #81qd #thoughtleader #medicalliaison #pharma

Introducing Susan Asante-Abedi (Bentsi-Enchill), Chief Strategy Officer here at 81qd/MKG. With over two decades of experience in strategy consulting in the pharmaceutical industry, Susan has a proven track record in developing customer-centric solutions that drive value to her clients. In her current role, she advises life science leaders on critical business issues across the product life cycle, with a focus on marketing, medical affairs and engagement strategy. Thank you, Susan, for your invaluable role in supporting our team and our clients. Learn more about Susan's role here at 81qd: https://lnkd.in/esBVtMwH #81qd #leadership #employeespotlight #dataanalytics

Most biopharma companies have spent the last few years focusing on a Big Data strategy, but data alone isn’t enough to address core business challenges. The true value lies in Big Analytics, aka the secret sauce that allows companies to turn data-driven insights into action. By leveraging Big Analytics, you can drive smarter decisions and optimize performance to consistently exceed expectations. Learn more about the importance of Big Analytics:  https://lnkd.in/effGAn9d #81qd #data #analytics #dataanalytics #biopharma #businessoperations

Swing by the 81qd booth at Fierce MASSWest to demo Pantheon, our configurable HCP profiling solution for Medical Affairs teams! #FierceMASS #MASSWest #medicalaffairs #81qd

Over the past decade, the pharmaceutical industry has undergone significant changes, including the emergent power of managed care, the declining use of sales reps, and the explosive growth of data and digital marketing tools. Despite all the change, one thing has remained constant, and that is the need for pharma companies to engage with thought leaders. As the pharma landscape continues to evolve, thought leader management has continued to be a complex rife with challenges, making thoughtful engagement planning and tracking more important than ever. With 81qd's proprietary technology, companies can now uncover objective data and find the right experts for their next engagement. Learn more on how 81qd can help organizations manage thought-leader relationships: https://lnkd.in/em5HwwKR #81qd #pharma #dataanalytics #thoughtleader #HCPengagement

The 81qd team is thrilled to be heading to San Diego for MASS West later this month as a proud silver sponsor! Our team is eager to connect with and hear from emerging biotech and pharma leaders at the premier West Coast conference for medical affairs professionals. We're looking forward to participating in discussions on building agile medical affairs teams from the ground up, exploring out-of-the-box strategies for MSLs to engage with KOLs and HCPs post-pandemic, developing effective medical communications plans for pre-launch success, and so much more. If you're attending this year's event, be sure to connect with our team at the conference! Learn more about MASS West: https://lnkd.in/e_9SsmFZ #81qd #MASSWest #medicalaffairs #biotech #pharma

We are excited to annouce Fletcher Rehbein's promotion to Senior Consultant, Strategy & Insights. Congratulations, Fletcher! #81qd #promotions #culture

As Executive Vice President of Health Care Analytics, Daniel Leszkiewicz reflects on his 18-year journey here at 81qd, highlighting how both he and the company have evolved over the years! When asked about his growth and how 81qd's work helps support rare disease patients, check out what he said. #81qd #DataAnalytics #EmployeeSpotlight #Healthcare #Analytics #RareDisease

If you’re attending ANA 2024 in Orlando this week, be sure to check out our new poster, presented by Lei Lv of Novo Nordisk on Sunday, September 15th from 5:30-7:30 pm EST.   In collaboration with Magnolia Market Access, our team utilized internal EHR data linked with social determinants of health (SDOH) to examine the pre-diagnostic journey of Alzheimer’s patients by disease stage. This innovative real-world analysis sheds light on the early clinical characteristics of AD patients in the U.S. and we invite all ANA attendees to explore our findings. We hope to see you there! #81qd #MagnoliaMarketAccess #ANA2024 #Alzheimers

Congratulations to our affliate company, Magnolia Innovation, for being recognized on the MM&M Agency 100 list!